×
About 145 results

ALLMedicine™ Acneiform Eruptions Center

Research & Reviews  71 results

Choosing Between Isotretinoin and Acitretin for Epidermal Growth Factor Receptor Inhibi...
https://doi.org/10.1016/j.jaad.2020.09.090
Journal of the American Academy of Dermatology; Costello CM, Hill HE et. al.

Oct 11th, 2020 - Choosing Between Isotretinoin and Acitretin for Epidermal Growth Factor Receptor Inhibitor and Small Molecule Tyrosine Kinase Inhibitor Acneiform Eruptions.|2020|Costello CM,Hill HE,Brumfiel CM,Yang YW,Swanson DL,|

Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.
https://doi.org/10.1136/postgradmedj-2020-137756
Postgraduate Medical Journal; Priyam P, Sil A et. al.

Apr 16th, 2020 - Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.|2020|Priyam P,Sil A,Bhanja DB,Mondol DK,|

Twelve cases of acneiform eruptions while on anti-CTLA4 therapy.
https://doi.org/10.1007/s00520-020-05381-5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer; Welborn M, Kubicki SL et. al.

Mar 8th, 2020 - We present the first detailed report of acneiform eruptions in patients on CTLA-4 inhibitor therapy. Acneiform eruptions commonly occur (up to 75-100%) as a cutaneous adverse event associated with EGFR inhibition; however, acneiform eruptions have...

Subungual Hemorrhage From an Epidermal Growth Factor Receptor Inhibitor
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor?channel=44
Josh A. Hammel, MD, Dean Elhag, MD et. al.

Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.

Follicular occlusion disorders in Down syndrome patients.
https://doi.org/10.1111/pde.14012
Pediatric Dermatology REFERENCES; Firsowicz M, Boyd M et. al.

Oct 18th, 2019 - Disorders involving follicular occlusion, such as hidradenitis suppurativa, folliculitis, acneiform eruptions, and pilonidal cysts, have shown an increased prevalence in the Down syndrome (DS) population, but there are limited published data exami...

see more →

Clinicaltrials.gov  71 results

Choosing Between Isotretinoin and Acitretin for Epidermal Growth Factor Receptor Inhibi...
https://doi.org/10.1016/j.jaad.2020.09.090
Journal of the American Academy of Dermatology; Costello CM, Hill HE et. al.

Oct 11th, 2020 - Choosing Between Isotretinoin and Acitretin for Epidermal Growth Factor Receptor Inhibitor and Small Molecule Tyrosine Kinase Inhibitor Acneiform Eruptions.|2020|Costello CM,Hill HE,Brumfiel CM,Yang YW,Swanson DL,|

Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.
https://doi.org/10.1136/postgradmedj-2020-137756
Postgraduate Medical Journal; Priyam P, Sil A et. al.

Apr 16th, 2020 - Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.|2020|Priyam P,Sil A,Bhanja DB,Mondol DK,|

Twelve cases of acneiform eruptions while on anti-CTLA4 therapy.
https://doi.org/10.1007/s00520-020-05381-5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer; Welborn M, Kubicki SL et. al.

Mar 8th, 2020 - We present the first detailed report of acneiform eruptions in patients on CTLA-4 inhibitor therapy. Acneiform eruptions commonly occur (up to 75-100%) as a cutaneous adverse event associated with EGFR inhibition; however, acneiform eruptions have...

Subungual Hemorrhage From an Epidermal Growth Factor Receptor Inhibitor
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor?channel=44
Josh A. Hammel, MD, Dean Elhag, MD et. al.

Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.

Follicular occlusion disorders in Down syndrome patients.
https://doi.org/10.1111/pde.14012
Pediatric Dermatology REFERENCES; Firsowicz M, Boyd M et. al.

Oct 18th, 2019 - Disorders involving follicular occlusion, such as hidradenitis suppurativa, folliculitis, acneiform eruptions, and pilonidal cysts, have shown an increased prevalence in the Down syndrome (DS) population, but there are limited published data exami...

see more →

News  3 results

Subungual Hemorrhage From an Epidermal Growth Factor Receptor Inhibitor
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor?channel=44
Josh A. Hammel, MD, Dean Elhag, MD et. al.

Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.

see more →